Pharmacogenetic testing, which involves using an individual's genetic information to determine the most effective drug and dose for them, has been rapidly adopted in academic healthcare centers in the United States and Europe. However, there is still resistance to this type of testing among healthcare providers due to factors such as cost, lack of education, and skepticism about its benefits. A survey of clinical pharmacologists found that while many believed pharmacogenetic testing was useful, they felt that more research and clinical trials were needed before widespread implementation. The survey also highlighted the need for diversity in research and testing populations to ensure equitable healthcare outcomes. Overall, there is support for the implementation of pharmacogenetic testing, but more research and education are needed.